Ewout Heylen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ewout Heylen has a total of 71 co-authors. Here are the top co-authors by number of shared publications:
Abdul Qayyum
National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, UK
1 shared publication- Adrien ter Schiphorst
Université Paris Cité, Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, Team Turc, Paris, France
1 shared publication Albert Clèrigues
Institute of Computer Vision and Robotics, University of Girona, Girona, Spain
1 shared publication- Alexandre Hutton
Department of Computational Biomedicine, Board of Governors Innovation Center, Cedars Sinai Medical Center , Los Angeles CA 90048
1 shared publication Andriy Myronenko
NVIDIA, Santa Clara, CA, USA
1 shared publicationAnne Mickan
Department of Medical Imaging, Radboud University Medical Center, Institute for Health Sciences, Nijmegen, The Netherlands
1 shared publication
Latest Publications
- 31 March 2026
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- p. ajnr.A9311
Deep learning-based non-contrast CT imaging markers enhance post-transfer DWI core volume prediction
Deep learning enables the extraction of ischemic lesion size and hypodensity imaging markers from noncontrast CT (DLNCCT) in patients with acute ischemic stroke, but it remains unclear whether those markers can predict post-transfer core volume. We performed a post-hoc analysis of prospectively enrolled patients transferred from a primary to a comprehensive center (PSC/CSC) for endovascular treatment (EVT). Using a validated deep-learning NCCT segmentation method, we quantified total lesion volume (per 10mL), modified net water uptake (mNWU %), and severely hypodense volume (≤26 HU per 10mL) and compared these markers with core-lab-rated ASPECTS (per point decrease) and CTP-based evaluation for their association with (adjusted regression coefficient [95%CI]) and predictive performance in addition to baseline variables (R2±SE) for post-transfer CSC-admission DWI core volume. We included 420 patients (239[57%] males) with a median age of 72 years (IQR:61;80). We observed 11.2mL (95%CI:8.3;14.1] larger post-transfer core volumes per point decrease in ASPECTS, 10.0mL (95%CI:6.8;13.3) and 20.0mL (95%CI:12.7;27.2) larger post-transfer core volumes per 10 mL increase in total and severely hypodense DLNCCT volume, respectively. mNWU was not associated with post-transfer core volume (p=0.63). In addition to clinical baseline and CTA variables, post-transfer core volume prediction with ASPECTS (R2:0.49±0.02) and DLNCCT (R2:0.50±0.02) did not differ significantly (p=0.58). Compared with using CTP imaging markers (R2:0.56±0.02), adding ASPECTS (R2:0.63±0.02, p<0.01) and DLNCCT (R2:0.65±0.01, p<0.01) improved performance for post-transfer core volume prediction. Total and severely hypodense DLNCCT volumes are independent predictors for post-transfer core volume. These DLNCCT markers improved CTP-based post-transfer core volume prediction.
- 31 March 2026
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- p. ajnr.A9311
Deep learning-based non-contrast CT imaging markers enhance post-transfer DWI core volume prediction
Deep learning enables the extraction of ischemic lesion size and hypodensity imaging markers from noncontrast CT (DLNCCT) in patients with acute ischemic stroke, but it remains unclear whether those markers can predict post-transfer core volume. We performed a post-hoc analysis of prospectively enrolled patients transferred from a primary to a comprehensive center (PSC/CSC) for endovascular treatment (EVT). Using a validated deep-learning NCCT segmentation method, we quantified total lesion volume (per 10mL), modified net water uptake (mNWU %), and severely hypodense volume (≤26 HU per 10mL) and compared these markers with core-lab-rated ASPECTS (per point decrease) and CTP-based evaluation for their association with (adjusted regression coefficient [95%CI]) and predictive performance in addition to baseline variables (R2±SE) for post-transfer CSC-admission DWI core volume. We included 420 patients (239[57%] males) with a median age of 72 years (IQR:61;80). We observed 11.2mL (95%CI:8.3;14.1] larger post-transfer core volumes per point decrease in ASPECTS, 10.0mL (95%CI:6.8;13.3) and 20.0mL (95%CI:12.7;27.2) larger post-transfer core volumes per 10 mL increase in total and severely hypodense DLNCCT volume, respectively. mNWU was not associated with post-transfer core volume (p=0.63). In addition to clinical baseline and CTA variables, post-transfer core volume prediction with ASPECTS (R2:0.49±0.02) and DLNCCT (R2:0.50±0.02) did not differ significantly (p=0.58). Compared with using CTP imaging markers (R2:0.56±0.02), adding ASPECTS (R2:0.63±0.02, p<0.01) and DLNCCT (R2:0.65±0.01, p<0.01) improved performance for post-transfer core volume prediction. Total and severely hypodense DLNCCT volumes are independent predictors for post-transfer core volume. These DLNCCT markers improved CTP-based post-transfer core volume prediction.
- Top Cited PapersOpen Access
- 9 August 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 7357
DeepISLES: a clinically validated ischemic stroke segmentation model from the ISLES'22 challenge
Diffusion-weighted MRI is critical for diagnosing and managing ischemic stroke, but variability in images and disease presentation limits the generalizability of AI algorithms. We present DeepISLES, a robust ensemble algorithm developed from top submissions to the 2022 Ischemic Stroke Lesion Segmentation challenge we organized. By combining the strengths of best-performing methods from leading research groups, DeepISLES achieves superior accuracy in detecting and segmenting ischemic lesions, generalizing well across diverse axes. Validation on a large external dataset (N = 1685) confirms its robustness, outperforming previous state-of-the-art models by 7.4% in Dice score and 12.6% in F1 score. It also excels at extracting clinical biomarkers and correlates strongly with clinical stroke scores, closely matching expert performance. Neuroradiologists prefer DeepISLES’ segmentations over manual annotations in a Turing-like test. Our work demonstrates DeepISLES’ clinical relevance and highlights the value of biomedical challenges in developing real-world, generalizable AI tools. DeepISLES is freely available at https://github.com/ezequieldlrosa/DeepIsles.
- 9 August 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 7357
Top Cited PapersOpen AccessDeepISLES: a clinically validated ischemic stroke segmentation model from the ISLES'22 challenge
Diffusion-weighted MRI is critical for diagnosing and managing ischemic stroke, but variability in images and disease presentation limits the generalizability of AI algorithms. We present DeepISLES, a robust ensemble algorithm developed from top submissions to the 2022 Ischemic Stroke Lesion Segmentation challenge we organized. By combining the strengths of best-performing methods from leading research groups, DeepISLES achieves superior accuracy in detecting and segmenting ischemic lesions, generalizing well across diverse axes. Validation on a large external dataset (N = 1685) confirms its robustness, outperforming previous state-of-the-art models by 7.4% in Dice score and 12.6% in F1 score. It also excels at extracting clinical biomarkers and correlates strongly with clinical stroke scores, closely matching expert performance. Neuroradiologists prefer DeepISLES’ segmentations over manual annotations in a Turing-like test. Our work demonstrates DeepISLES’ clinical relevance and highlights the value of biomedical challenges in developing real-world, generalizable AI tools. DeepISLES is freely available at https://github.com/ezequieldlrosa/DeepIsles.